Palladyne 10-Q Details Q3 Loss of $12.0M Despite Record $8.6M Revenue
PDYN sits 44% above its 52-week low of $2.66.
Summary
Palladyne's Q3 10-Q confirms record $8.6M revenue but a widened $13.4M operating loss, with $47.0M in cash and expired warrants/earn-outs clearing the dilution overhang.
Key Events · Earnings and Guidance · PDYN
-
Record Q3 Revenue, Wider Loss
Revenue rose 895% to $8.6M from $0.9M, but the operating loss widened to $13.4M as total operating expenses climbed 146% to $21.9M.
-
Nine-Month Net Loss of $36.9M
The nine-month net loss was $36.9M versus $11.5M net income a year earlier, a swing driven largely by a $33.1M prior-year non-cash warrant fair-value gain that did not recur.
-
Cash of $47.0M, 12-Month Runway
Cash, cash equivalents and marketable securities totaled $47.0M at September 30, 2026, versus $47.1M at December 31, 2025; management says this funds at least the next 12 months.
-
Backlog Grows to $18.7M
Backlog rose to $18.7M ($15.3M funded) from $13.9M at year-end, with most expected to convert over the next 12 to 18 months.
Analysis · PDYN · Technology
The headline numbers were already out this morning, but the full 10-Q shows what that growth cost: Q3 revenue jumped 895% to $8.6M while the operating loss widened to $13.4M and total operating expenses rose 146% to $21.9M. For the nine months, the net loss was $36.9M versus prior-year net income of $11.5M, though that swing is mostly accounting — last year included a $33.1M non-cash warrant fair-value gain that did not repeat. Cash and marketable securities held at $47.0M, which management says funds at least 12 months, and backlog grew to $18.7M from $13.9M at year-end. The capital-structure clean-up is a real positive: all 20.5M deSPAC warrants and the last 2.3M earn-out shares expired worthless in September, removing a large potential dilution overhang.
How filings like this one have moved
In the 30 days to Nov 10, 2026, 36.4% of the 3168 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, PDYN was trading at $3.82 on NASDAQ in the Technology sector, with a market capitalization of approximately $174.7M. The 52-week trading range was $2.66 to $10.00. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.